These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 12380405)
21. Merits of DMPA relative to other reversible contraceptive methods. Nelson A J Reprod Med; 2002 Sep; 47(9 Suppl):781-4. PubMed ID: 12380406 [TBL] [Abstract][Full Text] [Related]
22. Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications. Spencer AL; Bonnema R; McNamara MC Am J Med; 2009 Jun; 122(6):497-506. PubMed ID: 19486709 [TBL] [Abstract][Full Text] [Related]
23. Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception. Cameron ST; Glasier A; Johnstone A Contraception; 2012 May; 85(5):458-64. PubMed ID: 22079602 [TBL] [Abstract][Full Text] [Related]
24. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density. Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210 [TBL] [Abstract][Full Text] [Related]
25. Depot medroxyprogesterone acetate contraceptive injections and skeletal health. Renner RM; Edelman AB; Kaunitz AM Womens Health (Lond); 2010 May; 6(3):339-42. PubMed ID: 20426597 [No Abstract] [Full Text] [Related]
36. [Letter: Ovulation inhibitors in depot-form?]. Lauritzen C MMW Munch Med Wochenschr; 1975 Feb; 117(9):361. PubMed ID: 804646 [No Abstract] [Full Text] [Related]
37. Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate. Hapgood JP Endocrinology; 2013 Mar; 154(3):985-8. PubMed ID: 23429710 [No Abstract] [Full Text] [Related]
38. Initiation and continuation rates seen in 2-year experience with Same Day injections of DMPA. Nelson AL; Katz T Contraception; 2007 Feb; 75(2):84-7. PubMed ID: 17241834 [TBL] [Abstract][Full Text] [Related]